Prevention of delayed traumatic facial palsy.
A previous impression that corticotrophin provided prophylaxis against delayed traumatic facial palsy has now been confirmed by the results obtained from the first 50 patients so treated.
D000324:Adrenocorticotropic Hormone / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004427:Ear Diseases / Q000150:complications; D004487:Edema / Q000139:chemically induced; D005128:Eye Diseases / Q000139:chemically induced; D005151:Facial Injuries / Q000150:complications*; D005158:Facial Paralysis / Q000209:etiology / Q000517:prevention & control*; D006029:Glycosuria / Q000139:chemically induced; D006470:Hemorrhage / Q000150:complications; D006801:Humans; D008297:Male; D013701:Temporal Bone / Q000293:injuries
D000324:Adrenocorticotropic Hormone